Candriam S.C.A. Sage Therapeutics, Inc. Transaction History

Candriam S.C.A.

$17.1 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$18.62 - $26.95 $93,100 - $134,750	-5,000 Reduced 2.2%	222,000 $4.16 Million
Q2 2023 Aug 08, 2023	BUY	$40.65 - $59.54 $5.57 Million - $8.16 Million	137,000 Added 152.22%	227,000 $10.7 Million
Q1 2023 May 12, 2023	BUY	$37.27 - $46.57 $3.35 Million - $4.19 Million	90,000 New	90,000 $3.78 Million
Q4 2021 Feb 10, 2022	SELL	$37.06 - $47.11 $6.86 Million - $8.72 Million	-185,058 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$40.26 - $57.37 $1.87 Million - $2.67 Million	46,490 Added 33.55%	185,058 $8.2 Million
Q2 2021 Jul 20, 2021	SELL	$54.88 - $79.29 $333,615 - $482,003	-6,079 Reduced 4.2%	138,568 $7.87 Million
Q4 2020 Jan 22, 2021	SELL	$58.41 - $89.06 $271,781 - $414,396	-4,653 Reduced 3.12%	144,647 $12.5 Million
Q3 2020 Oct 19, 2020	BUY	$41.13 - $62.45 $5.98 Million - $9.07 Million	145,300 Added 3632.5%	149,300 $9.13 Million
Q2 2020 Jul 23, 2020	SELL	$25.95 - $43.15 $3.77 Million - $6.27 Million	-145,300 Reduced 97.32%	4,000 $5.11 Million
Q4 2019 Jan 21, 2020	BUY	$60.18 - $154.77 $601,800 - $1.55 Million	10,000 Added 7.18%	149,300 $11,000
Q3 2019 Oct 21, 2019	BUY	$140.29 - $189.96 $2.95 Million - $3.99 Million	21,000 Added 17.75%	139,300 $20,000
Q2 2019 Aug 01, 2019	SELL	$157.85 - $183.09 $9.47 Million - $11 Million	-60,000 Reduced 33.65%	118,300 $21.6 Million
Q1 2019 May 02, 2019	BUY	$89.33 - $163.65 $1.61 Million - $2.95 Million	18,000 Added 11.23%	178,300 $28.4 Million
Q4 2018 Feb 14, 2019	BUY	$81.94 - $139.71 $1.84 Million - $3.14 Million	22,500 Added 16.33%	160,300 $15.4 Million
Q3 2018 Nov 07, 2018	BUY	$138.11 - $169.04 $11.2 Million - $13.8 Million	81,400 Added 144.33%	137,800 $19.5 Million
Q2 2018 Aug 14, 2018	BUY	$140.36 - $175.76 $2.58 Million - $3.23 Million	18,400 Added 48.42%	56,400 $8.83 Million
Q4 2017 Feb 07, 2018	SELL	$60.72 - $167.34 $971,520 - $2.68 Million	-16,000 Reduced 29.63%	38,000 $6.26 Million
Q3 2017 Nov 03, 2017	BUY	$61.4 - $88.52 $3.32 Million - $4.78 Million	54,000	54,000 $3.36 Million

Others Institutions Holding SAGE

# of Institutions

198

Shares Held

46.5M

Call Options Held

402K

Put Options Held

209K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account